Inventor
VENKATESAN ARANAPAKAM M
US44 patents
⚠️ This page may combine multiple inventors who share the name “VENKATESAN ARANAPAKAM M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMERICAN CYANAMID CO
23 patentsUS5753648AMay 19, 1998
Tricyclic benzazepine vasopressin antagonists
AMERICAN CYANAMID CO70 citations96
US5536718AJul 16, 1996
Tricyclic benzazepine vasopressin antagonists
AMERICAN CYANAMID CO86 citations96
US5849735ADec 15, 1998
Tricyclic benzazepine vasopressin antagonists
AMERICAN CYANAMID CO89 citations95
US5780471AJul 14, 1998
Tricyclic benzazepine vasopressin antagonists
AMERICAN CYANAMID CO29 citations92
US5700796ADec 23, 1997
Tricyclic benzazepine vasopressin antagonists
AMERICAN CYANAMID CO20 citations92
US5294617AMar 15, 1994
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO26 citations92
US5281603AJan 25, 1994
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO24 citations92
US6340691B1Jan 22, 2002
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
AMERICAN CYANAMID CO42 citations91
US5532235AJul 2, 1996
Tricyclic benzazepine vasopressin antagonists
AMERICAN CYANAMID CO35 citations90
US5610156AMar 11, 1997
Tricyclic benzazepine vasopressin antagonists
AMERICAN CYANAMID CO14 citations82
US5436333AJul 25, 1995
Process for the preparation of tricyclic-heterocycles
AMERICAN CYANAMID CO15 citations74
US5358951AOct 25, 1994
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
AMERICAN CYANAMID CO19 citations74
US5292742AMar 8, 1994
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO7 citations74
US5284853AFeb 8, 1994
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO12 citations74
US5281604AJan 25, 1994
Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
AMERICAN CYANAMID CO12 citations74
US6358980B1Mar 19, 2002
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
AMERICAN CYANAMID CO8 citations72
US5405849AApr 11, 1995
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO2 citations63
US5358947AOct 25, 1994
Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones
AMERICAN CYANAMID CO6 citations63
US5294611AMar 15, 1994
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO2 citations63
US5292734AMar 8, 1994
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO5 citations63
US5284852AFeb 8, 1994
Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
AMERICAN CYANAMID CO2 citations63
US5594152AJan 14, 1997
Process for the preparation of tricyclic-heterocycles
AMERICAN CYANAMID CO0 citations52
US5286729AFeb 15, 1994
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
AMERICAN CYANAMID CO1 citations52
ASANA BIOSCIENCES LLC
8 patentsUS11103491B2Aug 31, 2021
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC2 citations71
US10751332B2Aug 25, 2020
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC2 citations71
US10471051B2Nov 12, 2019
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC3 citations70
US9896445B2Feb 20, 2018
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC3 citations70
US11925629B2Mar 12, 2024
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
ASANA BIOSCIENCES LLC0 citations60
US9533981B2Jan 3, 2017
Pyridine derivatives
ASANA BIOSCIENCES LLC0 citations50
US9371316B2Jun 21, 2016
Pyridine derivatives
ASANA BIOSCIENCES LLC0 citations49
US9266873B2Feb 23, 2016
Pyridine derivatives
ASANA BIOSCIENCES LLC0 citations49
WYETH CORP
5 patentsUS6753337B2Jun 22, 2004
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
WYETH CORP5 citations61
US6825354B2Nov 30, 2004
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors
WYETH CORP1 citations51
US7332506B2Feb 19, 2008
Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
WYETH CORP0 citations50
US6939870B2Sep 6, 2005
Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
WYETH CORP0 citations50
US7276611B2Oct 2, 2007
Process for synthesizing beta-lactamase inhibitor intermediates
WYETH CORP1 citations47
AMERICAN HOME PROD
4 patentsUS5521173AMay 28, 1996
Tricyclic benzazepine vasopressin antagonists
AMERICAN HOME PROD120 citations97
US5914339AJun 22, 1999
Substituted 1,3-benzodioxoles
AMERICAN HOME PROD10 citations71
US5965607AOct 12, 1999
Substituted Benzo[1,4]dioxines as antiobesity agents
AMERICAN HOME PROD4 citations63
US6083975AJul 4, 2000
Substituted benzo[1,4]dioxines as antiobesity agents
AMERICAN HOME PROD0 citations52